SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615219-17-000080
Filing Date
2017-11-06
Accepted
2017-11-06 08:43:36
Documents
56
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q flks201793010-q.htm 10-Q 729285
2 EXHIBIT 10.2 flks2017930ex-102.htm EX-10.2 95542
3 EXHIBIT 31.1 flks2017930ex-311.htm EX-31.1 10240
4 EXHIBIT 31.2 flks2017930ex-312.htm EX-31.2 10289
5 EXHIBIT 32.1 flks2017930ex-321.htm EX-32.1 9392
  Complete submission text file 0001615219-17-000080.txt   3926777

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT flks-20170930.xml EX-101.INS 791248
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20170930.xsd EX-101.SCH 25048
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20170930_cal.xml EX-101.CAL 52215
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20170930_def.xml EX-101.DEF 100750
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20170930_lab.xml EX-101.LAB 398951
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20170930_pre.xml EX-101.PRE 224955
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36812 | Film No.: 171178373
SIC: 2834 Pharmaceutical Preparations